NIH Funding Opportunities (Notices, PA, RFA)

Subscribe to NIH Funding Opportunities (Notices, PA, RFA) feed
Weekly Funding Opportunities and Policy Notices from the National Institutes of Health.
Updated: 2 hours 29 min ago

Notice of Special Interest (NOSI): Advancing Research on SUD with brain-based computational models

Tue, 2024-07-02 13:21
Notice NOT-DA-26-001 from the NIH Guide for Grants and Contracts

Standardizing Data and Metadata from Wearable Devices (R01 Clinical Trial Not Allowed)

Tue, 2024-07-02 13:21
Funding Opportunity PAR-24-250 from the NIH Guide for Grants and Contracts. The purpose of this NOFO is to support the creation of standards and related efforts that will allow researchers to easily access data from personal tracking devices. The awardees will be expected to partner with device manufacturers as well as the researcher community if the effort is going to be successful. It is expected that the awardees will create standards for personal tracking device data that serve the same purpose as the DICOM or Neuroimaging Informatics Technology Initiative (NIfTI) formats and standards do for medical image files.

D-START: Data Science Track Award for Research Transition (D/START) (R03-Clinical Trial Optional)

Mon, 2024-07-01 13:34
Funding Opportunity PAS-24-242 from the NIH Guide for Grants and Contracts. Data science is an important cross-cutting research approach in the 2022 - 2026 NIDA Strategic Plan and increasing the capacity of experts in addiction related data science is critical. The purpose of this Notice is to facilitate the entry of investigators to the area of addiction-related data science, including newly independent data scientists or established investigators seeking to incorporate novel and cutting-edge data science methodologies into their research programs for the first time. Through this opportunity, investigators will propose to apply emerging data science methods to answer critical questions requiring advanced data analytic strategies. Projects should be small in scale and answer specific research questions or provide preliminary data for a larger scale project. Applicants are encouraged to use existing datasets, follow FAIR principles, and, when applicable, attend to ethical concerns in the conduct of research involving human subjects. Ultimately, the aim is to expedite the development of robust research programs focused on the convergence of innovative data science techniques and addiction research, with initial projects serving as precursors for subsequent, more expansive research projects.

Extramural Loan Repayment Program for Clinical Researchers (LRP-CR)

Mon, 2024-07-01 10:36
Notice NOT-OD-24-134 from the NIH Guide for Grants and Contracts

Extramural Loan Repayment Program for Pediatric Research (LRP-PR)

Mon, 2024-07-01 10:36
Notice NOT-OD-24-135 from the NIH Guide for Grants and Contracts

Extramural Loan Repayment Program for Health Disparities Research (LRP-HDR)

Mon, 2024-07-01 10:35
Notice NOT-OD-24-136 from the NIH Guide for Grants and Contracts

Extramural Loan Repayment Program for Research in Emerging Areas Critical to Human Health (LRP-REACH)

Mon, 2024-07-01 10:35
Notice NOT-OD-24-137 from the NIH Guide for Grants and Contracts

Extramural Clinical Research Loan Repayment Program for Individuals from Disadvantaged Backgrounds (LRP-IDB)

Mon, 2024-07-01 10:34
Notice NOT-OD-24-138 from the NIH Guide for Grants and Contracts

Extramural Loan Repayment Program for Contraception and Infertility Research (LRP-CIR)

Mon, 2024-07-01 10:33
Notice NOT-OD-24-139 from the NIH Guide for Grants and Contracts

Early- and Late-Stage Clinical Trials for the Spectrum of Alzheimer's Disease/Alzheimer's Disease-Related Dementias and Age-Related Cognitive Decline (R01 Clinical Trial Optional)

Mon, 2024-07-01 04:10
Funding Opportunity RFA-AG-25-011 from the NIH Guide for Grants and Contracts. The purpose of this Notice of Funding Opportunity (NOFO) is to 1) invite applications that propose to develop and implement early to late stage clinical trials of promising pharmacological and non-pharmacological interventions to prevent and or treat the cognitive, behavioral,and neuropsychiatric changes associated with age-related cognitive decline and Alzheimer's disease (AD) and Alzheimer's disease-related dementias (ADRD) and 2) stimulate studies to enhance trial design and methods.

Alzheimer's Clinical Trials Consortium (ACTC) Clinical Trials (R01 Clinical Trial Required)

Mon, 2024-07-01 04:09
Funding Opportunity RFA-AG-25-010 from the NIH Guide for Grants and Contracts. This Notice of Funding Opportunity (NOFO) invites applications to develop and implement multi-site Phase Ib to III clinical trials of promising pharmacological and non-pharmacological interventions that may prevent, delay, or treat the symptoms of Alzheimer's disease (AD) and other age-related dementias using the Alzheimer's disease Clinical Trials Consortium (ACTC) trial coordination and management infrastructure.

Request for Information (RFI): Evolving the Network of the National Library of Medicine

Mon, 2024-07-01 03:28
Notice NOT-LM-24-001 from the NIH Guide for Grants and Contracts

Notice of Correction to PAR-23-199 "ClinGen Curation Expert Panels (U24 Clinical Trials not Allowed)"

Fri, 2024-06-28 12:31
Notice NOT-HD-24-025 from the NIH Guide for Grants and Contracts

NIH HEAL Initiative PainCare Clinician Training Program (PCTP): Mentored Patient-Oriented Research Career Development award (K23 - Clinical Trial Required)

Fri, 2024-06-28 12:24
Funding Opportunity PAR-24-220 from the NIH Guide for Grants and Contracts. The purpose of this NIH HEAL Initiative PAINCare Clinician Training Program (PCTP): Mentored Patient-Oriented Research Career Development award (K23) (Clinical Trial Required) is to support a cohort of new and well-trained, independent investigators. The program will provide independent NIH research support during the early-career phase to help awardees establish independent research programs in areas support by the NIH HEAL Initiatives Clinical Research in Pain Management program.

Pages